The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent β-thalassemia in Taiwan

Deferasirox is a novel once-daily, oral iron chelator. The aim of this study was to evaluate the long-term efficacy and tolerability of deferasirox in Taiwanese patients with transfusion-dependent β-thalassemia who have been treated with deferasirox for 7 years. Taiwanese patients aged ≥2 years with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Hematol
Asıl Yazarlar: Chang, Hsiu-Hao, Lu, Meng-Yao, Peng, Steven Shinn-Forng, Yang, Yung-Li, Lin, Dong-Tsamn, Jou, Shiann-Tarng, Lin, Kai-Hsin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2015
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4604499/
https://ncbi.nlm.nih.gov/pubmed/26404899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-015-2476-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller